Prospective Parallel Randomized, Double-Blind, Double-Dummy Controlled Clinical Trial Comparing Clomiphene Citrate and Metformin as the First-Line Treatment for Ovulation Induction in Nonobese Anovulatory Women with Polycystic Ovary Syndrome
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
CONTEXT: Although metformin has been shown to be effective in the treatment of anovulation in women with polycystic ovary syndrome (PCOS), clomiphene citrate (CC) is still considered to be the first-line drug to induce ovulation in these patients. OBJECTIVE: The goal of this study was to compare the effectiveness of metformin and CC administration as a first-line treatment in anovulatory women with PCOS. DESIGN: We describe a prospective parallel randomized, double-blind, double-dummy controlled clinical trial. SETTING: The study was conducted at the University "Magna Graecia" of Catanzaro, Catanzaro, Italy. PATIENTS: One hundred nonobese primary infertile anovulatory women with PCOS participated. INTERVENTIONS: We administered metformin cloridrate (850 mg twice daily) plus placebo (group A) or placebo plus CC (150 mg for 5 d from the third day of a progesterone withdrawal bleeding) (group B) for 6 months each. MEAN OUTCOME MEASURES: The main outcome measures were ovulation, pregnancy, abortion, and live-birth rates. RESULTS: The subjects of groups A (n = 45) and B (n = 47) were studied for a total of 205 and 221 cycles, respectively. The ovulation rate was not statistically different between either treatment group (62.9 vs. 67.0%, P = 0.38), whereas the pregnancy rate was significantly higher in group A than group B (15.1 vs. 7.2%, P = 0.009). The difference found between groups A and B regarding the abortion rate was significant (9.7 vs. 37.5%, P = 0.045), whereas a positive trend was observed for the live-birth rate (83.9 vs. 56.3%, P = 0.07). The cumulative pregnancy rate was significantly higher in group A than group B (68.9 vs. 34.0%, P < 0.001). CONCLUSIONS: Six-month metformin administration is significantly more effective than six-cycle CC treatment in improving fertility in anovulatory nonobese PCOS women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and there is no evidence-based need to continue metformin in these individuals (92)(93)(94).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [93]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“None of the currently available human insulin preparations have been demonstrated to cross the placenta (93-98).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [93]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Nugent, D., Vanderkerchove, P., Hughes, E., Arnot, M., & Lilford, R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000410.pub2 · Cited by 80
RetractedClomiphene citrate for ovulation induction in women with oligo-amenorrhoea
Hughes, E. G., Collins, J. A., & Vandekerckhove, P. (1996) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000056 · Cited by 75
Retracted(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Hirsutism: Implications, etiology, and management
Hatch, R., Rosenfield, R. L., Kim, M. H., & Tredway, D. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90746-8 · Cited by 1,014
Velazquez, E. M., Mendoza, S., Hamer, T., Sosa, F., & Glueck, C. J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90209-7 · Cited by 865
Franks, S. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.1.89 · Cited by 806
Clark, A. M., Thornley, B., Tomlinson, L., Galletley, C., & Norman, R. J. (1998) · Human Reproduction · doi:10.1093/humrep/13.6.1502 · Cited by 789
Metformin in polycystic ovary syndrome: systematic review and meta-analysis
Lord, J. M., Flight, I. H. K., & Norman, R. J. (2003) · BMJ · doi:10.1136/bmj.327.7421.951 · Cited by 786
Cited by
Items 101–200 of 279
Therapeutic strategies for ovulation induction in infertile women with polycystic ovary syndrome
Cristello, F., Cela, V., Artini, P. G., & Genazzani, A. R. (2005) · Gynecological Endocrinology · doi:10.1080/09513590500463360 · Cited by 31
“On the contrary, in a prospective, parallel, randomized, double-blind, double-dummy controlled clinical trial comparing CC and metformin as the first-line treatment for ovulation induction in nonobese PCOS anovulatory women, other authors showed that 6-month metformin administration is significantly more effective tha…”
BackgroundXiao, J., Chen, S., Zhang, C., & Chang, S. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.705368 · Cited by 30
Zhang, J., Si, Q., & Li, J. (2017) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.331.11764 · Cited by 30
Clomiphene Versus Metformin for Ovulation Induction in Polycystic Ovary Syndrome: The Winner Is ….
Barbieri, R. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1393 · Cited by 31
Mohsen, I. A., ElKattan, E. A., Nabil, H., & Khattab, S. (2012) · Journal of Clinical Ultrasound · doi:10.1002/jcu.22006 · Cited by 26
Metformin: direct inhibition of rat ovarian theca-interstitial cell proliferation
Will, M. A., Palaniappan, M., Peegel, H., Kayampilly, P. P., & Menon, K. M. J. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.04.010 · Cited by 31
Yuan, L., Wu, H., Huang, W., Bi, Y., Qin, A., & Yang, Y. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00772-7 · Cited by 25
Braakhekke, M., Kamphuis, E., van Rumste, M. M., Mol, F., van der Veen, F., & Mol, B. W. (2014) · Human Reproduction · doi:10.1093/humrep/deu069 · Cited by 29
Hanjalic-Beck, A., Gabriel, B., Schaefer, W., Zahradnik, H.-P., Schories, M., Tempfer, C., Keck, C., & Denschlag, D. (2010) · Gynecological Endocrinology · doi:10.3109/09513591003686379 · Cited by 28
Brand, K. M. G., Gottwald‐Hostalek, U., & Andag‐Silva, A. (2025) · Women s Health · doi:10.1177/17455057241311759 · Cited by 38
“21 Treatment with metformin reduced the risk of preterm delivery according to meta-analyses of randomised trials from 2022 (RR 0.42 (95% CI: 0.25–0.71)) 59 and 2016 (OR 0.38 (95% CI: 0.16–0.90)).”
InfluentialKai, Y., Kawano, Y., Yamamoto, H., & Narahara, H. (2015) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-015-0023-2 · Cited by 25
“It was shown to induce the regularity of menstrual cycles, improve hyperinsulinemia, and attenuate hyperandrogenemia in clinical studies of women with PCOS [12,13].”
BackgroundPolycystic Ovarian Syndrome Management Options
Bates, G. W., & Propst, A. M. (2012) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2012.10.001 · Cited by 25
Metformin hydrochloride and recurrent miscarriage in a woman with polycystic ovary syndrome
Palomba, S., Falbo, A. I., Orio, F., Russo, T., Tolino, A., & Zullo, F. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.09.063 · Cited by 22
Drugs for anovulatory infertility in polycystic ovary syndrome
Al-Inany, H. G., & JOHNSON, N. P. (2006) · BMJ · doi:10.1136/bmj.332.7556.1461 · Cited by 22
Hadžiomerović, D., Wildt, L., Weiss, J. M., Moeller, K., Mattle, V., & Seeber, B. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.02.041 · Cited by 22
Use of exogenous gonadotropins in anovulatory women: a technical bulletin
(2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.08.003 · Cited by 27
“Another study, not included in the 2003 systematic review, reported 18 pregnancies in 28 women with HA across 72 cycles of treatment (25% per cycle), but only 16 pregnancies in 61 hyperandrogenic women with PCOS across 205 cycles of treatment (8% per cycle) (35).”
BackgroundInfluentialBordewijk, E. M., Wang, R., van Wely, M., Costello, M. F., Norman, R. J., Teede, H., Gurrin, L. C., Mol, B. W., & Li, W. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa031 · Cited by 18
Effects of metformin treatment on pregnancy outcomes in patients with polycystic ovary syndrome
Raperport, C., Chronopoulou, E., & Homburg, R. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1889366 · Cited by 26
“In slim women with PCOS metformin was more effective than clomiphene in achieving clinical pregnancy and live birth rates High quality, double blind RCT [29] Palomba, 2005”
BackgroundAKAY, G. A. Ç., Erdoğan, F. G., & Gürler, A. (2012) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2012.05691.x · Cited by 20
Current trends in the treatment of polycystic ovary syndrome with desire for children
Checa, M. Á. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3779 · Cited by 22
“Other studies 28–31 observed benefits when metformin was included, however, they did not provide data on pregnancy rates and appeared to be small studies.”
Peng, G., Yan, Z., Liu, Y., Li, J., Ma, J., Tong, N., & Wang, Y. (2023) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-023-01075-9 · Cited by 47
Sugiura‐Ogasawara, M., Sato, T. A., Suzumori, N., Kitaori, T., Kumagai, K., & Ozaki, Y. (2008) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2008.00662.x · Cited by 25
Leeman, L., & Acharya, U. (2009) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443610902829414 · Cited by 22
“The spontaneous abortion rate was significantly lower in the metformin group, however there was only a positive trend toward a higher live birth rate in the metformin group (p¼ 0.07) (Palomba et al. 2005).”
ResultInfluentialJOHNSON, N. P., Bontekoe, S., & Stewart, A. W. (2011) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2011.01295.x · Cited by 18
Reproductive Endocrinology in Recurrent Pregnancy Loss
Krog, M. C., Nielsen, H. S., Christiansen, O. B., & Kolte, A. M. (2016) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000225 · Cited by 21
Metformin in the Treatment of Polycystic Ovary Syndrome
Ab, M. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785294609 · Cited by 20
Liu, K. E., TATARYN, I. V., & Sagle, M. A. (2006) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32202-2 · Cited by 18
Cheshire, J., Garg, A., Smith, P., Devall, A., Coomarasamy, A., & Dhillon‐Smith, R. K. (2025) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2025.05.038 · Cited by 20
Baran, Ş. Y., Apı, M., Göksedef, B. P. Ç., & Cetin, A. (2010) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-010-1497-y · Cited by 16
Cheng, J., Lv, J., Li, C., Xue, Y., Huang, Z., & Zheng, W. (2010) · Journal of International Medical Research · doi:10.1177/147323001003800406 · Cited by 17
Insulin-sensitizing agents and reproductive function in polycystic ovary syndrome patients
Palomba, S., Falbo, A. I., Orio, F., & Zullo, F. (2008) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e328307ebc5 · Cited by 18
Polycystic ovary syndrome and metformin in pregnancy
Lilja, A. E., & Mathiesen, E. R. (2006) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/00016340600780441 · Cited by 18
“In a recent controlled trial, 100 non-obese PCOS patients were randomized to receive either metformin or clomifene for six months (33).”
BackgroundMethodInfluentialSun, X., Zhang, D., & Zhang, W. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-2756-5 · Cited by 18
Mahran, A., Abdelmeged, A. N., Shawki, H., Moheyelden, A., & Ahmed, A. M. (2016) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.29252/ijrm.14.1.9 · Cited by 17
“CC has been shown by many studies to have an anti-estrogenic effect on the endometrial development, blastocyst implantation, on the quality of the oocytes/embryos and on the cervical mucus affecting sperm transport, and early embryonic development (13-15).”
BackgroundClomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome
Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., et al. (2007) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000265909.61668.01 · Cited by 14
Metformin use in infertile patients with polycystic ovary syndrome: an evidence-based overview
Palomba, S., Oppedisano, R., Tolino, A., Orio, F., & Zullo, F. (2008) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60592-5 · Cited by 18
Capp, E., Jauckus, J., Corleta, H. V. E., Tóth, B., Strowitzki, T., & Germeyer, A. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.05.012 · Cited by 12
Costello, M., & Ledger, W. J. (2012) · Women s Health · doi:10.2217/whe.12.14 · Cited by 15
“+ P for up to 6 months 150 mg/day 3–7 + P for up to 6 months ↔ OR per Pa ↑ PR per Pa ↓ MCR per pregnancy ↔ LBR per pregnancy [86]”
BackgroundAchieving a Successful Pregnancy in Women with Polycystic Ovary Syndrome
Araki, T., Elias, R. T., Rosenwaks, Z., & Poretsky, L. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.08.003 · Cited by 13
Huang, H., He, Y., Wan, L., Wei, W., Li, Y., Xie, R., Guo, S., Wang, Y., Jiang, J., Chen, B., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9353 · Cited by 13
Ghobadi, C., Amer, S. A. K. S., Lashen, H., Lennard, M. S., Ledger, W. J., & Rostami‐Hodjegan, A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.01.058 · Cited by 14
“Most studies have reported ovulation rates of 60%–85% and pregnancy rates of 30%–40% with CC (7).”
BackgroundManagement of Infertility in Women with Polycystic Ovary Syndrome: A Practical Guide
Stadtmauer, L., & Oehninger, S. (2005) · Treatments in Endocrinology · doi:10.2165/00024677-200504050-00002 · Cited by 17
Metformin during Pregnancy in Polycystic Ovary Syndrome: Another Vitamin Bites the Dust
Legro, R. S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2301 · Cited by 15
Palomba, S., Orio, F., & Zullo, F. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701414212 · Cited by 13
“These data disagree with an our previous head-to-head RCT [11] comparing metformin with CC, which demonstrated that, in an infertile non-obese PCOS population, metformin is equally as effective as CC for inducing ovulation but is superior in terms of pregnancy rate.”
BackgroundResultInfluentialTehrani, F. R., & Behboudi‐Gandevani, S. (2015) · InTech eBooks · doi:10.5772/59591 · Cited by 16
Panidis, D., Τζιόμαλος, Κ., Papadakis, E. P., Kandaraki, E., & Katsikis, I. (2013) · HORMONES · doi:10.14310/horm.2002.1403 · Cited by 13
The role of metformin in ovulation induction: Current status
Elnashar, A. M. (2011) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2010.10.003 · Cited by 14
Metformin and polycystic ovary syndrome
Lebinger, T. G. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328089f0ea · Cited by 15
Diav‐Citrin, O., Steinmetz-Shoob, S., Shechtman, S., & Ornoy, A. (2018) · Reproductive Toxicology · doi:10.1016/j.reprotox.2018.05.007 · Cited by 12
Polycystic ovary syndrome and abnormal glucose tolerance
Teede, H. J., & Stuckey, B. G. A. (2007) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2007.tb01271.x · Cited by 11
Zhao, H., Zhang, J., Xing, C., Cheng, X., & He, B. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01367-7 · Cited by 18
Abuelghar, W. M., Elkady, O. S., & Khamees, A. A. (2013) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2013.05.002 · Cited by 15
Polycystic Ovary Syndrome: A Review of Management Outcomes in a Low Resource Setting
GU, E. C. E. (2013) · Journal of Womens Health Issues and Care · doi:10.4172/2325-9795.1000110 · Cited by 15
Treating the Polycystic Ovary Syndrome the Old-Fashioned Way
Guzick, D. S. (2007) · New England Journal of Medicine · doi:10.1056/nejme068295 · Cited by 11
Le syndrome des ovaires polykystiques (SOPK)
Torre, A., & Fernandez, H. (2007) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2007.04.002 · Cited by 23
Garthwaite, H., Stewart, J. A., & Wilkes, S. (2021) · Human Fertility · doi:10.1080/14647273.2021.1872803 · Cited by 11
“Eight studies only recruited patients diagnosed with PCOS (Amer et al., 2017; Ayaz et al., 2013; Johnson et al., 2010; Legro et al., 2007; Legro et al., 2014; Palomba et al., 2005; Palomba et al., 2007; Zain et al., 2009), and four studies recruited patients diagnosed with WHO group II ovulatory disorders or normogona…”
BackgroundInfluentialWeerakiet, S., Sophonsritsuk, A., Lertvikool, S., Satirapot, C., Leelaphiwat, S., & Jultanmas, R. (2011) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2010.01507.x · Cited by 11
“However, it remains the advantage of a combination of metformin and CC compared with CC alone remains controversial.(3,11,12,15) In fact, there are several regimens of metformin and CC combination for ovulation induction.”
MethodResultDoll, I., Doll, R., & Bühling, K. J. (2011) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-2014-7 · Cited by 10
“In recent literature, metformin definitely enjoys a good reputation due to its results and its minor side effects [39, 44].”
BackgroundPregnancy Complications in PCOS
Homburg, R. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_11 · Cited by 11
Choice of treatment for women with polycystic ovary syndrome
Lobo, R. A. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.011 · Cited by 10
Treatment of Infertility in the Polycystic Ovary Syndrome
Panidis, D., & Farmakiotis, D. (2007) · New England Journal of Medicine · doi:10.1056/nejmc070603 · Cited by 10
Insulin Resistance in Polycystic Ovary Syndrome
Sung, Y. (2008) · Korean Diabetes Journal · doi:10.4093/kdj.2008.32.1.1 · Cited by 8
Treatment for polycystic ovary syndrome: a critical appraisal of treatment options
Nader, S. (2008) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.3.3.349 · Cited by 9
The role of metformin in the treatment of polycystic ovary syndrome (PCOS).
Wang, H. (2006) · PubMed · Cited by 9
Polycystic Ovary Syndrome and Ovulation Induction
Yildiz, B. O., & Azziz, R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_35 · Cited by 9
Insulin-sensitising drugs for polycystic ovary syndrome
Tang, T. H., Lord, J. M., Norman, R. J., Yasmin, E., & Balen, A. H. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub2 · Cited by 9
Günday, Ö. K., Erdoğan, M. Ö., Pehlivan, A., & Yılmazer, M. (2022) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-022-02577-y · Cited by 12
“Besides, metformin may reduce body weight, although it has modest efficacy in managing PCOS and PCOS-related obesity [23].”
BackgroundOvulation induction in polycystic ovary syndrome—how do metformin and clomifene citrate compare?
Pesant, M.-H., & Baillargeon, J. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0529 · Cited by 8
Ovulation induction in polycystic ovary syndrome
Gupta, S., Metterle, L., Thakkar, P., Surti, N., Chandra, A., & Agarwal, A. K. (2009) · Cited by 8
Ovulation Induction in Anovulatory Patients with Polycystic Ovary Syndrome
Palomba, S., Falbo, A. I., Russo, T., & Zullo, F. (2006) · Current Drug Therapy · doi:10.2174/157488506775268498 · Cited by 8
Pagidas, K., Carson, S. A., McGovern, P. G., Barnhart, H. X., Myers, E. R., Legro, R. S., Diamond, M. P., Carr, B. R., Schlaff, W. D., Coutifaris, C., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.05.047 · Cited by 7
Polycystic ovary syndrome and miscarriage: a narrative review
Bui, L. M., Aghajanova, L., Lathi, R. B., & Sokalska, A. (2024) · F&S Reviews · doi:10.1016/j.xfnr.2024.100078 · Cited by 6
(2005) · CRC Press eBooks · doi:10.1201/b14349-20 · Cited by 6
Early pregnancy failure: a review
Exalto, N., Christiansen, O. B., Farquharson, R. G., & Jauniaux, E. R. M. (2006) · European Clinics in Obstetrics and Gynaecology · doi:10.1007/s11296-006-0050-9 · Cited by 7
Metformin and polycystic ovary syndrome.
Omran, M. Y. S. (2007) · Europe PMC (PubMed Central) · Cited by 7
Wang, X., Wang, J., Xu, Y., & Huang, L. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3486-z · Cited by 7
“2 %; and consistent with other reports, 30–90 % and 13–88 % [9, 21, 26].”
RetractedMehrabian, F., & Afghahi, M. (2013) · PubMed Central · Cited by 10
Fattah, G. A., Almohamady, M., & Hamed, D. A. (2013) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2013.05.003 · Cited by 6
Current procedures for managing polycystic ovary syndrome
Massicotte, M.-H., Langlois, F., & Baillargeon, J. (2010) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.09.74 · Cited by 5
Meikle, A. W. (2008) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)79202-3 · Cited by 5
Metformin Use in Adolescents: Old and New Therapeutic Perspectives
Soliman, F. A. A. T. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000472 · Cited by 6
Nestler, J. E. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0113 · Cited by 5
Metformin: an important tool for endocrinology in the West Indies. New tricks for an old drug
Teelucksingh, S., & Pereira, L. M. P. (2009) · The British Journal of Diabetes · doi:10.1177/1474651409346766 · Cited by 5
Metformin in therapy naive patients with polycystic ovary syndrome
Palomba, S., & Falbo, A. I. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmm049 · Cited by 4
Insulin levels, insulin resistance and the use of metformin in polycystic ovary syndrome
Hutchison, S. K., Zoungas, S., & Teede, H. J. (2007) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2007.tb00889.x · Cited by 4
Mechanistic insight into nanomedicine for polycystic ovary syndrome
Butt, M. A., Tabassum, S., Hardy, R., & Kiyani, M. M. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10709-7 · Cited by 13
“The first conventional medication discovered for the treat - ment of PCOS was clomiphene [57 , 58 ].”
Wal, A., Dash, B., Jaiswal, V., Gupta, D., & Mishra, A. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13587-3.00018-7 · Cited by 7
Defining prediabetes in polycystic ovarian syndrome
Trolice, M. P. (2011) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2011.12008 · Cited by 7
Conception and Lifestyle - Integrative Psychosomatics in Ovarian Insufficiency
Egloff, G., Bender, I., & Roemer, J. (2018) · Journal of Andrology and Gynaecology · doi:10.13188/2332-3442.1000033 · Cited by 3
“Generally, although off-label in Gemany, metformin often leads to a decrease of high androgen concentration, to an increased rate of ovulations, and to a higher rate of gravidity [49].”
Background“Crazy Woman Juice”: Making Sense of Women's Clomiphene Infertility Treatments
Leyser‐Whalen, O. (2014) · Women s Reproductive Health · doi:10.1080/23293691.2014.966031 · Cited by 3
Insulin sensitizers for women with polycystic ovarian syndrome
Galal, A. F., & Mitwally, M. F. (2009) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.4.2.183 · Cited by 4
Ovulation Induction in Anovulatory Patients with Polycystic Ovary Syndrome
Falbo, A. I., Palomba, S., Russo, T., Cello, A. D., & Zullo, F. (2010) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-1092 · Cited by 4
“Recent data on anovulatory nonobese PCOS women, in fact, showed that metformin and CC were similarly efficacy to induce ovulation, whereas the pregnancy and the abortion rates resulted significantly higher and lower, respectively, in women treated with metformin, while a trend was observed for the live-birth rate [59].”
ResultPCOS and metformin: from pharmacology to clinical use for women's health
Genazzani, A. D., Ricchieri, F., Prati, A., Chierchia, E., Rattighieri, E., Bosco, G., Despini, G., Campedelli, A., Farinetti, A., & Santagni, S. (2012) · IRIS UNIMORE (University of Modena and Reggio Emilia) · Cited by 5
WISNIEWSKI, M., & Petersen, M. (2009) · JAAPA · doi:10.1097/01720610-200904000-00013 · Cited by 3
Stracquadanio, M., & Ciotta, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-16760-2_6 · Cited by 3
Insulin sensitizers in the treatment of polycystic ovary syndrome
Teede, H. J. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545191.006 · Cited by 3
Insulin-Sensitizing Drugs for the Treatment of Infertility in Polycystic Ovary Syndrome
Ryan, C. S., & Nestler, J. E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_10 · Cited by 4
“Similarly, in another study where metformin was compared with clomiphene citrate in 100 nonobese women with pcas for 6 months, the ovulation rates during the treatment period did not differ ( 16 ).”
BackgroundMethodResultInfluentialA 40-Year-Old Woman With Diabetes Contemplating Pregnancy After Gastric Bypass Surgery
Coustan, D. R. (2008) · JAMA · doi:10.1001/jama.299.17.jrr80003 · Cited by 3
Polycystic Ovary Syndrome: Update on Treatment Options and Treatment Considerations for the Future
Farrell-Turner, K. A. (2011) · Clinical Medicine Insights Women s Health · doi:10.4137/cmwh.s6715 · Cited by 3
Metadata
- Authors
- Palomba, S., Orio, F., Falbo, A., Manguso, F., Russo, T., Cascella, T., Tolino, A., Carmina, E., Colao, A., & Zullo, F.
- Affiliations
- Magna Graecia University (IT)
- Departments of Molecular and Clinical Endocrinology and Oncology (F.O., T.C., A.C.), 80138 Naples, Italy;
- Internal Medicine (F.M.), 80138 Naples, Italy;
- Federico II University Hospital (IT)
- University of Palermo (IT)
- Corresponding author
- Palomba, Stefano
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-07-01
- Volume
- 90
- Issue
- 7
- Pages
- 4068-4074
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2126438731
- Cited by
- 279
- References
- 43
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 9 · 2021: 6 · 2020: 6 · 2019: 3 · 2018: 6 · 2017: 9 · 2016: 8 · 2015: 8 · 2014: 10 · 2013: 18 · 2012: 17
- FWCI
- 35.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- CINECA IRIS Institutial research information system (Parthenope University of Naples) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Keywords
- polycystic ovary syndrome, clomiphene citrate, metformin, ovulation induction, anovulation, infertility, pregnancy rate, live birth rate, abortion rates, non-obese women, first-line therapy, ovulation rate, cumulative pregnancy rate, insulin sensitizers, ovulation-inducing drugs
- MeSH terms
- Adult, Anovulation, Clomiphene, Double-Blind Method, Female, Humans, Metformin, Ovulation Induction, Polycystic Ovary Syndrome, Pregnancy, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.